Cargando…

Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma

Human glioma, in particular, malignant forms such as glioblastoma exhibit dismal survival rates despite advances in treatment strategies. A population of glioma cells with stem-like features, glioma cancer stem-like cells (GCSCs), contribute to renewal and maintenance of the tumor cell population an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Guifa, Best, Benjamin, Mania-Farnell, Barbara, James, Charles David, Tomita, Tadanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342987/ https://www.ncbi.nlm.nih.gov/pubmed/28278424 http://dx.doi.org/10.1016/j.neo.2017.01.006

Ejemplares similares

Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application
por: Nayak, Sonali, et al.
Publicado: (2020)

WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas
por: Wadhwani, Nitin, et al.
Publicado: (2023)

Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy
por: Xi, Guifa, et al.
Publicado: (2017)

Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
por: Chen, Zirong, et al.
Publicado: (2021)

Nuclear localization of folate receptor alpha: a new role as a transcription factor
por: Boshnjaku, Vanda, et al.
Publicado: (2012)

Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas()
por: Lewis, Rebecca, et al.
Publicado: (2019)

Pediatric Suprasellar Germ Cell Tumors: A Clinical and Radiographic Review of Solitary vs. Bifocal Tumors and Its Therapeutic Implications
por: Esfahani, Darian R., et al.
Publicado: (2020)

Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.
por: Yamada, N., et al.
Publicado: (1996)

Bone morphogenetic protein-4 and bone morphogenetic protein receptors expressions in the adult rat eye
por: Maruyama-Koide, Yuka, et al.
Publicado: (2017)

Role of Pax3 acetylation in the regulation of Hes1 and Neurog2
por: Ichi, Shunsuke, et al.
Publicado: (2011)

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma
por: Sheu, Meei-Ling, et al.
Publicado: (2022)

The expression and potential function of bone morphogenetic proteins 2 and 4 in bovine trophectoderm
por: Pennington, Kathleen A, et al.
Publicado: (2012)

Bone morphogenetic protein 4 is involved in cadmium-associated bone damage
por: Wan, Yu, et al.
Publicado: (2022)

The potential roles of aquaporin 4 in malignant gliomas
por: Lan, Yu-Long, et al.
Publicado: (2017)

Matrix Gla protein maintains normal and malignant hematopoietic progenitor cells by interacting with bone morphogenetic protein-4
por: Kuronuma, Kana, et al.
Publicado: (2020)

The Classic: Bone Morphogenetic Protein
por: Urist, Marshall R., et al.
Publicado: (2009)

Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells
por: Haubold, Maike, et al.
Publicado: (2010)

Role of bone morphogenetic protein-7 in renal fibrosis
por: Li, Rui Xi, et al.
Publicado: (2015)

Wif1 Mediates Coordination of Bone Morphogenetic Protein and Wnt Signaling in Neural and Glioma Stem Cells
por: Xu, Congdi, et al.
Publicado: (2022)

Osteoinduction by combining bone morphogenetic protein (BMP)-2 with a bioactive novel nanocomposite
por: Sharma, A., et al.
Publicado: (2012)

Bone morphogenetic protein 7 mediates stem cells migration and angiogenesis: therapeutic potential for endogenous pulp regeneration
por: Liang, Cheng, et al.
Publicado: (2022)

Suppression of bone morphogenetic protein inhibitors promotes osteogenic differentiation: therapeutic implications
por: Heliotis, Manolis, et al.
Publicado: (2008)

Bone morphogenetic protein signaling is a possible therapeutic target in gynecologic cancer
por: Fukuda, Tomohiko, et al.
Publicado: (2022)

Bone morphogenetic protein-2: a potential regulator in scleral remodeling
por: Hu, Jianmin, et al.
Publicado: (2008)

Beyond osteogenesis: an in vitro comparison of the potentials of six bone morphogenetic proteins
por: Rivera, Jessica C., et al.
Publicado: (2013)

Nuclear variants of bone morphogenetic proteins
por: Felin, Jenny E, et al.
Publicado: (2010)

Bone Morphogenetic Proteins: Periodontal Regeneration
por: Rao, Subramaniam M, et al.
Publicado: (2013)

Bone morphogenetic protein guts it out
por: Leslie, Mitch
Publicado: (2013)

Bone morphogenetic proteins: The anomalous molecules
por: Jain, Aena Pundir, et al.
Publicado: (2013)

Bone Morphogenetic Proteins and Diabetic Retinopathy
por: Elmasry, Khaled, et al.
Publicado: (2021)

Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas
por: Jha, Mithilesh Kumar, et al.
Publicado: (2013)

Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension
por: Caestecker, Mark De, et al.
Publicado: (2001)

A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression
por: Zhou, Kaijia, et al.
Publicado: (2020)

Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4
por: Shiozaki, Yasuyuki, et al.
Publicado: (2013)

Bone Morphogenetic Protein-2 in Development and Bone Homeostasis
por: Halloran, Daniel, et al.
Publicado: (2020)

Absorbable collagen sponges loaded with recombinant bone morphogenetic protein 9 induces greater osteoblast differentiation when compared to bone morphogenetic protein 2
por: Fujioka‐Kobayashi, Masako, et al.
Publicado: (2017)

Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer
por: Steinert, Andre F, et al.
Publicado: (2009)

Potential Roles of Bone Morphogenetic Protein (BMP)-9 in Human Liver Diseases
por: Herrera, Blanca, et al.
Publicado: (2014)

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
por: Goulding, Susan R., et al.
Publicado: (2020)

Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation
por: Govier-Cole, Alistair E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c1klh9ccc6jov88m8v1o723kqb